triiodothyronine has been researched along with Macular Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AnandBabu, K; Angayarkanni, N; Sen, P | 1 |
| Bharathselvi, M; Biswas, S; Coral, K; Narayanansamy, A; Ramakrishnan, S; Raman, R; Selvi, R; Sulochana, KN | 1 |
2 other study(ies) available for triiodothyronine and Macular Degeneration
| Article | Year |
|---|---|
Oxidized LDL, homocysteine, homocysteine thiolactone and advanced glycation end products act as pro-oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic effect in ARPE-19 cells.
Topics: Cells, Cultured; Cytokines; Glycation End Products, Advanced; Homocysteine; Humans; Lipoproteins, LDL; Macrophages; Macular Degeneration; Neovascularization, Pathologic; Oxidative Stress; Retinal Pigment Epithelium | 2019 |
Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study.
Topics: Aged; Copper; Female; Glutathione; Homocysteine; Humans; Macular Degeneration; Male; Middle Aged; Oxidative Stress; Thiobarbituric Acid Reactive Substances | 2016 |